Healthcare Communicators Must Respond to Industry Changes

Dramatic changes in regulations that govern the FDA include increased monitoring of digital media and a new emphasis on safety. FDA guru Wayne Pines talks with pharma specialist Mark Senak about education, litigation and what healthcare communicators need to do to stay apace with this “whole new environment.”

Will Social Media Stamp Out Email?

Is social media marketing responsible for the “impending demise” of email? The digital specialists from Fleishman DNA examine the platform’s decline, including how the changes could affect brands.

Posted on February 8th, 2012 | More B2C · Digital & Social Media · Mobile · Small Business Owners
Facebook 2.IPO: Why Communicators Should Watch

While Facebook prepares to go public, communicators appear to be in for a huge learning experience. In a PRWeek article, International Advisory Board member John Onoda weighs in — and suggests we’ll see “a new chapter of PR unfold.”

Read: Facebook From the 50-Yard Line

Posted on February 8th, 2012 | More Analysts & Investors · Digital & Social Media · Financial Communications
The Role of Digital Communications and ‘Pharmacovigilance’

In an article in PharmaVoice, pharma specialist Mark Senak discusses pharmacovigilance communication and explains why the best digital strategy includes “the concept of a two-way exchange.”

Read: Best Practices in Pharmacovigilance

Posted on February 3rd, 2012 | More Crisis Communications · Digital & Social Media · Healthcare